We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

2 hedge funds and large institutions have $12.5K invested in ENZON PHARMACEUTICALS INC in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

37% less capital invested

Capital invested by funds: $19.7K → $12.5K (-$7.26K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$12K – – –
CFA
2
CT Financial Advisors
Pennsylvania
$470 – – –

ENZN Hedge Fund Activity: Q1 2017 in Review

2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q1 2017, worth a combined $12.5K — down 37% from $19.7K a quarter earlier.

Fund positioning in ENZN was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $12.5K of ENZON PHARMACEUTICALS INC stock for Q1 2017, down 37% quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q1 2017 and 0 closed out.

Based on aggregated 13F filings for Q1 2017.